Head-to-head · Cost-Efficiency Index
Rewinding RX vs Vital Edge
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Rewinding RX
Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line.
Visit Rewinding RXVital Edge
Shoppers who want compounded, oral and brand-name GLP-1 options from one practice, with prices listed up front.
Visit Vital EdgeThe verdict
Rewinding RX and Vital Edge tie on the Cost-Efficiency Index at 66/100, so neither wins outright on the numbers, so choose on fit. Rewinding RX: Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line. Vital Edge: Shoppers who want compounded, oral and brand-name GLP-1 options from one practice, with prices listed up front.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Rewinding RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Rewinding RX | Vital Edge |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 66/100 |
| Semaglutide / mo | $139/moMicrodose tier, compounded | $350/moCompounded injection, flat monthly fee at every dose; oral capsules $199/mo |
| Tirzepatide / mo | $189/moMicrodose tier, compounded | $450/moCompounded injection, flat monthly fee at every dose; oral capsules $269/mo |
| Semaglutide / yr (modeled) | $1,668 | $4,200 |
| Tirzepatide / yr (modeled) | $2,268 | $5,400 |
| Coverage | All 50 states | Not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #187 | #193 |
Rewinding RX
66/100Where the value is
- Flat pricing within each product regardless of dose
- Publishes the FDA compounded-medication disclaimer and states pharmacies are '503A'/'503B' FDA-regulated facilities
- Corporate entity is disclosed (Rewinding RX Ltd.)
The tradeoffs
- Four separate GLP-1 SKUs exist at four different prices under similar names
- No compounding pharmacy is individually named, only generic '503A'/'503B' language
Vital Edge
66/100Where the value is
- Every program price is listed on the homepage, and each includes the consultation, medication and shipping
- Flat monthly fee with no upcharge as your dose rises
- Unusually wide menu: compounded injections, compounded oral semaglutide ($199) and tirzepatide ($269) capsules, and brand Ozempic ($705), Mounjaro ($835), Wegovy ($990) and Rybelsus ($645)
The tradeoffs
- Its Terms of Service and HIPAA Notice links lead to a page-not-found screen, and no cancellation or refund terms are published
- If you aren't prescribed medication, you're charged an $80 telehealth consult fee
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.